Oncolytics Biotech Inc.
About Oncolytics Biotech Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Grant T: - FT: Grant |
A: 5000000 MR: - FA: $5 million FAN: 5000000 |
D: 2023-09-26 FD: 2023-09-26 |
1 investors |
| 2 |
RT: Public Offering T: - FT: Public Offering |
A: 15000750 MR: - FA: US$15,000,750 FAN: 15000750 |
D: 2023-08-08 FD: 2023-08-08 |
2 investors |
| 3 |
RT: Equity Offering T: - FT: Equity Offering |
A: 15000750 MR: - FA: US$15,000,750 FAN: 15000750 |
D: 2023-07-31 FD: 2023-07-31 |
1 investors |
Growth Metrics
Team & Leadership
Jared Kelly
Chief Executive Officer & Director
Kirk Look
Chief Financial Officer
Thomas C. Heineman
Chief Medical Officer
Allison Hagerman
Vice President, Product Development
Andrew Aromando
Chief Business Officer
Amy Levin
Vice President, Clinical Operations
Recent News
Oncolytics Biotech Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- oncolyticsbiotech.com
- Industries
- Biotechnology / Healthcare
- Company Size
- ~360 employees (est.)
- Locations
-
Vancouver, BC, Canada
SAN DIEGO and CALGARY, AB
SAN DIEGO and CALGARY +2 more
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro